Testosterone explains why women more prone to asthma
An international research team has revealed for the first time that testosterone protects males against developing asthma, helping to explain why females are two times more likely to develop asthma than males after puberty. The study showed that…
IDT Receives Victorian Manufacturing Hall of Fame Award for Medical Technologies and Pharmaceuticals
Recognition of excellence in Victorian Advanced Manufacturing 10 May 2017, Melbourne: Australian pharmaceutical manufacturing and drug development company IDT Australia Limited (ASX: IDT) has received a Victorian Manufacturing Hall of Fame award in the High Growth Sector of…
MTPConnect to open 2017 applications for its Project Fund Program
Interested parties encouraged to start preparing their applications to share in the $8.2 million of available funding. MTPConnect – the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector – has announced that the second round…
Landmark Agreement Signed with RMIT for Australian Medicinal Cannabis Initiatives
Leading Australian research university, Royal Melbourne Institute of Technology and MGC Pharmaceuticals have signed a Binding Memorandum of Understanding to collaborate on a full suite of medicinal cannabis research initiatives, initially centred on genetics and cultivation. Under the…
Industry led consortium accelerates regenerative medicine sector
An industry-led consortium is set to begin projects that will link industry partners with regenerative medicine academic research and boost the growth of this emerging sector. The consortium, called the Regenerative Medicine Industry Interface, will accelerate commercialisation and…
New Hudson Institute Director and CEO announced
We are pleased to announce that Professor Elizabeth Hartland has accepted a position as the new Director and CEO of Hudson Institute of Medical Research. Professor Hartland obtained her BSc (Hons) majoring in Microbiology and Biochemistry and subsequently…
BioCurate CEO Appointed
An outstanding industry leader with exceptional national and global experience in successfully propelling important biomedical discoveries out of the lab and into the market has been appointed inaugural CEO of BioCurate Pty Ltd. This AUD $80 million venture…
Westpac Businesses of Tomorrow 2017 – Trajan Scientific and Medical Top 20
Right from our very beginning in 1817, Westpac has been guided by the same purpose: TO SUPPORT THE ECONOMIC PROGRESS OF AUSTRALIAN BUSINESSES. As we reach our 200th anniversary, that guiding purpose remains. To help the next generation…
Australia’s ProTA accelerates the development of immunotherapy to treat peanut allergy
Allergy immunotherapy company ProTA Therapeutics Pty Ltd (ProTA) will accelerate the development of a possible treatment for life-threatening peanut allergy with the appointment of its new CEO. ProTA has appointed former Mesoblast Vice President Operations Dr. Suzanne Lipe,…
Bionic Vision Technologies raises $US18m from State Path Capital, China Huarong
The Australian university-owned company in the race to develop a bionic eye to restore sight has been saved from its own near plunge into darkness after raising $US18 million ($23.6 million) from Chinese investors including the nephew of Hong…
The Medical Technologies and Pharmaceuticals (MTP) Roadmap – unlocking future growth opportunities for Australia
A changing global landscape The global MTP industry is on the cusp of enormous growth globally due to a range of factors including ageing populations, the growth of emerging markets seeking better health services and unprecedented innovation in…
New abilities to enhance cancer research at the Australian Synchrotron
It gave me great pleasure to today unveil the newest research tool that Australian scientists and researchers have in the fight against cancer. The Australian Synchrotron’s new multi-million dollar Australian Cancer Research Foundation (ACRF) Detector will fast-track new…
